Standard
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. / Pantazis, Nikos; Morrison, Charles; Amornkul, Pauli N; Lewden, Charlotte; Salata, Robert A; Minga, Albert; Chipato, Tsungai; Jaffe, Harold; Lakhi, Shabir; Karita, Etienne; Porter, Kholoud; Meyer, Laurence; Touloumi, Giota; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group ; Kirk, Ole.
I:
P L o S One, Bind 7, Nr. 3, 2012, s. e32369.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Pantazis, N, Morrison, C, Amornkul, PN, Lewden, C, Salata, RA, Minga, A, Chipato, T, Jaffe, H, Lakhi, S, Karita, E, Porter, K, Meyer, L, Touloumi, G, CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group
& Kirk, O 2012, '
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa',
P L o S One, bind 7, nr. 3, s. e32369.
https://doi.org/10.1371/journal.pone.0032369APA
Pantazis, N., Morrison, C., Amornkul, P. N., Lewden, C., Salata, R. A., Minga, A., Chipato, T., Jaffe, H., Lakhi, S., Karita, E., Porter, K., Meyer, L., Touloumi, G., CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group
, & Kirk, O. (2012).
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
P L o S One,
7(3), e32369.
https://doi.org/10.1371/journal.pone.0032369Vancouver
Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A o.a.
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
P L o S One. 2012;7(3):e32369.
https://doi.org/10.1371/journal.pone.0032369Author
Pantazis, Nikos ; Morrison, Charles ; Amornkul, Pauli N ; Lewden, Charlotte ; Salata, Robert A ; Minga, Albert ; Chipato, Tsungai ; Jaffe, Harold ; Lakhi, Shabir ; Karita, Etienne ; Porter, Kholoud ; Meyer, Laurence ; Touloumi, Giota ; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group ; Kirk, Ole. / Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa. I: P L o S One. 2012 ; Bind 7, Nr. 3. s. e32369.
Bibtex
@article{abd4efed8edc4b65bb884cdbc2e47de4,
title = "Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa",
abstract = "It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicable to African populations.",
author = "Nikos Pantazis and Charles Morrison and Amornkul, {Pauli N} and Charlotte Lewden and Salata, {Robert A} and Albert Minga and Tsungai Chipato and Harold Jaffe and Shabir Lakhi and Etienne Karita and Kholoud Porter and Laurence Meyer and Giota Touloumi and Ole Kirk and Ole Kirk",
year = "2012",
doi = "10.1371/journal.pone.0032369",
language = "English",
volume = "7",
pages = "e32369",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",
}
RIS
TY - JOUR
T1 - Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa
AU - Pantazis, Nikos
AU - Morrison, Charles
AU - Amornkul, Pauli N
AU - Lewden, Charlotte
AU - Salata, Robert A
AU - Minga, Albert
AU - Chipato, Tsungai
AU - Jaffe, Harold
AU - Lakhi, Shabir
AU - Karita, Etienne
AU - Porter, Kholoud
AU - Meyer, Laurence
AU - Touloumi, Giota
AU - CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group
AU - Kirk, Ole
PY - 2012
Y1 - 2012
N2 - It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicable to African populations.
AB - It is unknown whether HIV treatment guidelines, based on resource-rich country cohorts, are applicable to African populations.
U2 - 10.1371/journal.pone.0032369
DO - 10.1371/journal.pone.0032369
M3 - Journal article
C2 - 22412867
VL - 7
SP - e32369
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 3
ER -
